Objective: The paper analyzes the experience of drug price monitoring at home, abroad, provides reference, suggestions for optimizing the drug price monitoring mechanism. Methods: We analyze the typical practices of drug price monitoring in typical regions at home, abroad, identify the difficulties in monitoring, propose optimization countermeasures. Results: All regions gradually began to explore the drug price monitoring based on the bidding, procurement platform, but there were still challenges to carry out whole-process price monitoring of drugs, medical consumables, medical service projects across the country. Conclusion: We need establish a systematic drug price supervision mechanism to form a closed-loop drug price monitoring system, make full use of the national medical insurance information platform to improve the monitoring efficiency, improve the accuracy, comprehensiveness of data to objectively reflect medical price information, combine with a variety of monitoring methods to reach a wider monitoring range, improve the application of medical price monitoring
Key words
drug price /
price monitoring /
bidding procurement /
implementation path
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 王星云. 价格监管的大数据嵌入与工具优化[J].宏观经济管理,2020(02):66-72.
[2] Republic of the Philippines. Electronic Drug Price Monitoring System [EB/OL].[2021-05-16] .https://pharma.doh.gov.ph/electronic-drug-price-monitoring-system/.
[3] Government of Canada. Patented Medicine Prices Review Board[EB/OL].[2021-05-16] .https://www.canada.ca/en/patented-medicine-prices-review/services/regulatory-process.html.
[4] 张方,朱越.加拿大专利药品政府管制定价政策介绍[J].中国药物经济学, 2012 (1) :15-19, 24.
[5] Patented Medicine Prices Review Board. Compendium of Policies, Guidelines and Procedure[EB/OL]. [2016-05-27] . http://www.pmprb-cepmb.gc.ca/view.asp?ccid=492.
[6] 刘昕,史录文.日本药品价格管理启示[J].中国新药杂志,2008,17(23),1994.
[7] 日本中央社会保险医疗协会.特定补偿医用耗材价格调査结果[R].日本:中央社会保险医疗协会,2015.
[8] 殷伊蓉,常峰,吕梦凝.日本与澳大利亚的医用耗材定价和补偿机制分析及启示[J].中国卫生经济,2017,36(10):42-45.
[9] 广东省物价局课题组.医用耗材价格管理研究(下)[J].市场经济与价格,2010,(05):20-27.
[10] MANCHIKANTI L, SINGH V, BENYAMIN R M, et al. Reframing Medicare physician payment policy for2019: a look at proposed policy[J]. Pain physician, 2018(21):415-432.
[11] American Medical Association. RVS Update Committee (RUC): RVS Update Process[EB/OL]. [2021-05-16] .https://www.ama-assn.org/about/rvs-update-committee-ruc/rvs-update-committee-ruc.
[12] MANCHIKANTI L, SINGH V, BENYAMIN R M, et al. Reframing Medicare physician payment policy for2019: a look at proposed policy[J]. Pain physician, 2018(21):415-432.
[13] LAUGESEN M J.The resource-based relative value scale andphysician reimbursement policy[J].Chest,2014,146( 5) : 1413-1419
[14] Independent Hospital Pricing Authority. Understanding the NEP and NEC2018-19[EB/OL]. [2021-05-17] .https://www.ihpa.gov.au/sites/default/files/publications/understanding_the_nep_and_nec_2018-19.pdf.
[15] 徐源,何江江,陈珉惺,等.药品集中采购国际经验及对我国国家层面带量采购的启示[J].中国卫生经济,2021, 40(4):4.
[16] 李海燕.价格总水平监测技术创新分析[J].中国市场,2019(06):184+186.
[17] 赵永金. 浅析当前价格监测工作面临的形势[J].中小企业管理与科技(上旬刊),2020(06):156-157.
[18] 刘颖. 新时期价格监测工作探讨[J].财经界,2020(36):237-238.
[19] 李文红. 基层部门价格监测预警体系构建研究[J].中国集体经济,2022(01):68-69.
[20] 陈秋玲. 社会预警机制研究[M].经济管理出版社,2009.
[21] 马宝成,王立刚.新时代中国应急管理的全面创新与发展[J].中国应急管理科学,2022(05):4-15.
[22] 陈胜辉,李策划.马克思主义政治经济学视阈下我国医疗问题研究[J].当代经济研究,2018(04):30-38.
[23] 王学军. 创新价格监管方式探索监管服实现新途径——泰州市物价局积极开拓市场价格监测工作新思路[J].价格理论与实践,2017(7):2.
[24] 王佳锐. 我国价格监测预警体系存在的问题及对策探究[J].价格月刊,2014,(11):14-17.
[25] 赵小平. 价格管理实务[M].中国市场出版社, 2005.
